Completed
A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis
NCT01292187
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
- Locations
-
- Diablo Clinical Research, Inc. Walnut Creek, California, United States
- Innovative Research of West Florida, Inc. Clearwater, Florida, United States
- Bethesda Health Research Bethesda, Maryland, United States
- Clinical Pharmacology Study Group Worcester, Massachusetts, United States